Holen Sie sich die Stockscreener-App
21.15
7.85%
1.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TVTX?
Forum
Prognose
Aktiensplit
Travere Therapeutics Inc Aktie (TVTX) Neueste Nachrichten
Transcript : Travere Therapeutics, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 02 - MarketScreener
Travere Therapeutics Inc. stock trend forecastJuly 2025 Pullbacks & Weekly High Return Opportunities - Newser
Travere Therapeutics at Cantor Conference: Strategic Insights on FILSPARI By Investing.com - Investing.com Canada
Travere Therapeutics Inc. recovery potential after sell off2025 Big Picture & High Win Rate Trade Alerts - Newser
What is the earnings history of Travere Therapeutics Inc.Price Action & Verified Momentum Watchlists - khodrobank.com
Travere Therapeutics, Inc.'s (NASDAQ:TVTX) Price Is Right But Growth Is Lacking - 富途牛牛
Why Travere Therapeutics Inc. is moving todayWeekly Trade Recap & Daily Profit Maximizing Trade Tips - Newser
Will Travere Therapeutics Inc. continue its uptrendQuarterly Risk Review & High Win Rate Trade Alerts - Newser
Travere Therapeutics Inc. stock prediction for this weekPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Is Travere Therapeutics Inc.’s growth already priced inExit Point & AI Forecast for Swing Trade Picks - khodrobank.com
Will Travere Therapeutics Inc. outperform small cap indexes2025 Geopolitical Influence & Safe Entry Zone Identification - khodrobank.com
How to interpret RSI for Travere Therapeutics Inc. stockMarket Trend Review & AI Driven Stock Reports - Newser
Travere Therapeutics shares rise 4.74% intraday after presenting positive long-term data for pegtibatinase at the International Congress of Inborn Errors of Metabolism. - AInvest
Can Travere Therapeutics Inc. be the next market leaderWeekly Trade Analysis & Capital Efficient Trade Techniques - khodrobank.com
Travere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism - Business Wire
Should you hold or exit Travere Therapeutics Inc. now2025 Market Trends & Growth Focused Stock Pick Reports - Newser
Chart based analysis of Travere Therapeutics Inc. trendsJuly 2025 Price Swings & Accurate Trade Setup Notifications - Newser
Technical analysis overview for Travere Therapeutics Inc. stockEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is Travere Therapeutics Inc. stock ready for a breakoutJuly 2025 Review & Expert Approved Momentum Ideas - Newser
Is Travere Therapeutics Inc. trending in predictive chart modelsInsider Buying & Verified Entry Point Detection - Newser
Earnings visualization tools for Travere Therapeutics Inc.2025 Stock Rankings & Expert Approved Momentum Ideas - Newser
Statistical indicators supporting Travere Therapeutics Inc.’s strength2025 Buyback Activity & Target Return Focused Picks - Newser
Travere Therapeutics: Strategic Positioning in Renal Disease with Near-Term Catalysts and Valuation Potential - AInvest
Nephrotic Syndrome Pipeline Analysis, 2025 by DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squibb, ChemoCentryx, SynAct Pharm - Barchart.com
Transcript : Travere Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-02-2025 03 - MarketScreener
Can Travere Therapeutics Inc. rally from current levels2025 Investor Takeaways & Verified Trade Idea Suggestions - Newser
Benchmark Reaffirms Buy Rating on Ligand with Raised PT to $175. - AInvest
What is Travere Therapeutics Inc.’s book value per shareTrade Analysis Report & Daily Oversold Stock Bounce Ideas - khodrobank.com
Risk vs reward if holding onto Travere Therapeutics Inc.Trend Reversal & Consistent Growth Stock Picks - Newser
Is Travere Therapeutics Inc. reversing from oversold territoryJuly 2025 Opening Moves & Consistent Profit Trade Alerts - Newser
Aug Levels: What is Travere Therapeutics Inc.’s book value per shareJuly 2025 Intraday Action & Community Consensus Trade Signals - khodrobank.com
Is now the right time to enter Travere Therapeutics Inc.July 2025 Spike Watch & Detailed Earnings Play Alerts - khodrobank.com
How to monitor Travere Therapeutics Inc. with trend dashboardsChart Signals & High Accuracy Swing Trade Signals - Newser
Pullback Watch: Does Travere Therapeutics Inc. have pricing powerJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - khodrobank.com
Using data filters to optimize entry into Travere Therapeutics Inc.Forecast Cut & High Accuracy Trade Alerts - Newser
Why Travere Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Levels & Weekly High Return Opportunities - Newser
Tick level data insight on Travere Therapeutics Inc. volatilityDividend Hike & Free High Return Stock Watch Alerts - Newser
Identifying reversal signals in Travere Therapeutics Inc.2025 Price Momentum & Reliable Trade Execution Plans - Newser
Multi asset correlation models including Travere Therapeutics Inc.Quarterly Profit Report & AI Powered Market Trend Analysis - Newser
Price action breakdown for Travere Therapeutics Inc.2025 Earnings Impact & Real-Time Volume Analysis Alerts - Newser
Visualizing Travere Therapeutics Inc. stock with heatmapsQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - Newser
Travere Therapeutics Inc. Attempts Reversal From Key Support getLinesFromResByArray error: size == 0 - classian.co.kr
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):